Tag Archives: Approves

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults Print this page Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive… Read More »

FTC approves UnitedHealth Group $4.3 billion acquisition of DaVita, with conditions

The Federal Trade Commission has approved UnitedHealth Group’s $ 4.3 billion acquisition of DaVita Medical Group, with conditions. UnitedHealth Group and DaVita have agreed to divest DaVita Medical Group’s provider organization in the Las Vegas Area, known as HealthCare Partners of Nevada, to Intermountain Healthcare in Utah, no later than 40 days after acquisition. The… Read More »

FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients

Print this page RALEIGH, N.C.  –  May 13,  2019  –  Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA), broadening its indication to be a first-line treatment of blepharospasm (involuntary blinking) in adult patients. “Merz is proud to offer a first-line… Read More »